Provided by Tiger Trade Technology Pte. Ltd.

GraniteShares YieldBOOST Bitcoin ETF

5.57
+0.02000.36%
Post-market: 5.55-0.0200-0.36%16:44 EDT
Volume:25.64K
Turnover:142.61K
Market Cap:11.03M
PE:- -
High:5.57
Open:5.56
Low:5.56
Close:5.55
52wk High:22.44
52wk Low:5.43
Shares:1.98M
Float Shares:1.98M
Volume Ratio:1.00
T/O Rate:1.29%
Dividend:9.31
Dividend Rate:167.15%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

The $4 Billion Signal: Bitcoin Isn't Trading The Buyback — It's Trading What Comes Next

Macro World​
·
Yesterday

World Liberty launches $4B USD1 on Canton Network

cryptonews
·
2 hours ago

Bitcoin Bull Score hits 80, but $83K close is key

cryptonews
·
2 hours ago

CoinDesk Bitcoin Price Index Gained 0.24% to $78934.96

Dow Jones
·
2 hours ago

LIVE Markets-Tech Finds Its Footing, but Wall Street's Rally Lacks Conviction

Reuters
·
2 hours ago

Top Cryptocurrencies Mixed; Bitcoin Holds Above $78,000 Level

MT Newswires Live
·
3 hours ago

Crypto market enters extreme greed for first time since 2024

cryptonews
·
3 hours ago

Dow Jones Top Markets Headlines at 3 PM ET: Canada Targets U.S. Metals, Fish, Foods, Motorcycles in Retaliatory Tariff Package | Bitcoin ...

Dow Jones
·
4 hours ago

Goldman Sachs backs crypto stocks amid Bitcoin breakout

cryptonews
·
4 hours ago

The 1996 Warning & Crypto Pivot

Blockhead
·
5 hours ago

Bitcoin Breaches $81,000 Mark as ETF Inflows Accelerate Crypto Rally

Deep News
·
5 hours ago

Bitcoin Rallies 0.2%

Dow Jones
·
6 hours ago

Dow Jones Top Markets Headlines at 1 PM ET: Bitcoin Rally Pauses After Jumping to Three-Month High | Canada ...

Dow Jones
·
6 hours ago

Author of "Rich Dad Poor Dad" Warns Holders of These "Fake Assets" Will Grow Poorer

Deep News
·
6 hours ago

Bitcoin's Blistering Rally Just Hit the Brakes. What Happens Next.

Dow Jones
·
Yesterday

Dow Jones Top Markets Headlines at 11 am ET: Bitcoin Rally Pauses After Jumping to 3-Month High | He ...

Dow Jones
·
Yesterday

Bitcoin Rally Pauses After Jumping to 3-Month High

Dow Jones
·
Yesterday

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma

GlobeNewswire
·
Yesterday

Bitcoin Rally Faces Critical Test as Spot and Futures Demand Surge

Stock News
·
Yesterday

Bitcoin Faces $1.5B Liquidation Showdown at Key Price Zones

Stock News
·
Yesterday